{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\" and docket_id = \"FDA-2008-N-0326\" sorted by posted_date descending", "rows": [["FDA-2008-N-0326-0348", "FDA", "FDA-2008-N-0326", "Reference 12 - New England Journal of Medicine, Mechanism of Disease The New B-Lactamases  re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background", "Supporting & Related Material", "Background Material", "2012-07-04T04:00:00Z", 2012, 7, null, null, "2012-07-04T16:54:14Z", null, 0, 0, "090000648064e653"], ["FDA-2008-N-0326-0346", "FDA", "FDA-2008-N-0326", "References (Pfizer - Comment) re FDA-2008-N-0326-0165 - Background", "Supporting & Related Material", "Background Material", "2012-07-04T04:00:00Z", 2012, 7, null, null, "2012-07-04T15:15:48Z", null, 0, 0, "0900006480788190"], ["FDA-2008-N-0326-0345", "FDA", "FDA-2008-N-0326", "Office of the Executive Secretariat (OES) Response to Council of State Territorial Epidemiologists (CSTE) - Letter re FDA-2008-N-0326-0333", "Other", "Letter(s)", "2012-07-03T04:00:00Z", 2012, 7, null, null, "2012-07-04T15:49:08Z", null, 0, 0, "09000064810121c1"], ["FDA-2008-N-0326-0338", "FDA", "FDA-2008-N-0326", "See FDA-2008-N-0326-0302", "Supporting & Related Material", "Reference (external attachments)", "2012-04-18T04:00:00Z", 2012, 4, null, null, "2012-04-24T21:16:10Z", null, 0, 0, "0900006480fd8b41"], ["FDA-2008-N-0326-0333", "FDA", "FDA-2008-N-0326", "See FDA-2008-N-0326-0344", "Supporting & Related Material", "Background Material", "2012-03-29T04:00:00Z", 2012, 3, null, null, "2012-07-04T15:53:44Z", null, 0, 0, "0900006480fe3bfb"], ["FDA-2008-N-0326-0269", "FDA", "FDA-2008-N-0326", "American Academy of Pediatrics re FDA-2008-N-0326-0268", "Supporting & Related Material", "Reference (external attachments)", "2012-03-06T05:00:00Z", 2012, 3, null, null, "2012-03-06T16:28:40Z", null, 0, 0, "0900006480fcb04e"], ["FDA-2008-N-0326-0283", "FDA", "FDA-2008-N-0326", "The Veterinary Pharmacy (TVP), Inc. - Request for Extension", "Other", "Request for Extension", "2012-03-06T05:00:00Z", 2012, 3, "2012-01-06T05:00:00Z", "2012-03-07T04:59:59Z", "2012-03-08T20:13:45Z", null, 0, 0, "0900006480fcf456"], ["FDA-2008-N-0326-0177", "FDA", "FDA-2008-N-0326", "New Animal Drugs; Orders of Prohibition: Cephalosporin Drugs; Extralabel Animal Drug Use", "Rule", "Final Rule", "2012-01-06T05:00:00Z", 2012, 1, "2012-01-06T05:00:00Z", "2012-03-07T04:59:59Z", "2012-07-05T02:01:56Z", "2012-00035", 0, 0, "0900006480f8ecbc"], ["FDA-2008-N-0326-0176", "FDA", "FDA-2008-N-0326", "New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Revocation of Order of Prohibition; Withdrawal", "Rule", "NWL-Notice of Withdrawl", "2008-11-26T05:00:00Z", 2008, 11, "2008-11-26T05:00:00Z", null, "2008-12-20T16:26:21Z", "E8-28093", 0, 0, "09000064807c1087"], ["FDA-2008-N-0326-0172", "FDA", "FDA-2008-N-0326", "Attachment 2 - Executive Summary and Reference List 1-16, 8-41 (Pfizer - Comment) re FDA-2008-N-0326-0165 and FDA-2008-N-0326-0346", "Supporting & Related Material", "Background Material", "2008-11-04T05:00:00Z", 2008, 11, null, null, "2012-07-04T15:30:52Z", null, 0, 0, "09000064807940aa"], ["FDA-2008-N-0326-0173", "FDA", "FDA-2008-N-0326", "See FDA-2008-N-0326-0116 (American College of Poultry Veterinarians - Comment)", "Supporting & Related Material", "Background Material", "2008-11-04T05:00:00Z", 2008, 11, null, null, "2012-07-04T17:00:54Z", null, 0, 0, "0900006480794057"], ["FDA-2008-N-0326-0051", "FDA", "FDA-2008-N-0326", "Sample Write-In Campaign 1 [Multiple Submitters=6] - Form Letter Comment", "Other", "FL-Form Letter", "2008-08-18T04:00:00Z", 2008, 8, "2008-08-18T04:00:00Z", null, "2012-03-07T17:19:37Z", null, 0, 0, "09000064806caf24"], ["FDA-2008-N-0326-0049", "FDA", "FDA-2008-N-0326", "New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition; Extension of Comment Period; Delay of Effective Date of Final Rule", "Rule", "Delay of Effective Date", "2008-08-18T04:00:00Z", 2008, 8, "2008-08-18T04:00:00Z", "2008-11-04T04:59:59Z", "2012-01-27T23:43:15Z", "E8-18967", 0, 0, "09000064806ca625"], ["FDA-2008-N-0326-0036", "FDA", "FDA-2008-N-0326", "American Association of Small Ruminant Practitioner - Request for Extension Comment Due Date", "Other", "EXT-Request for Extension Comment Due Date", "2008-08-10T04:00:00Z", 2008, 8, "2008-08-10T04:00:00Z", null, "2008-08-10T22:23:19Z", null, 0, 0, "09000064806b7ab7"], ["FDA-2008-N-0326-0029", "FDA", "FDA-2008-N-0326", "American Association of Bovine Practitioners - Request for Extension Comment Due Date", "Other", "EXT-Request for Extension Comment Due Date", "2008-08-05T04:00:00Z", 2008, 8, "2008-08-05T04:00:00Z", null, "2013-07-27T22:19:07Z", null, 0, 0, "090000648068cb7f"], ["FDA-2008-N-0326-0025", "FDA", "FDA-2008-N-0326", "American Association of Bovine Practitioners - Request for Extension Comment Due Date", "Other", "EXT-Request for Extension Comment Due Date", "2008-07-22T04:00:00Z", 2008, 7, "2008-07-22T04:00:00Z", null, "2013-08-11T04:27:03Z", null, 0, 0, "090000648068d52e"], ["FDA-2008-N-0326-0026", "FDA", "FDA-2008-N-0326", "Pfizer, Inc. - Request for Extension Comment Due Date", "Other", "EXT-Request for Extension Comment Due Date", "2008-07-22T04:00:00Z", 2008, 7, "2008-07-22T04:00:00Z", null, "2013-07-27T22:19:18Z", null, 0, 0, "090000648068d596"], ["FDA-2008-N-0326-0024", "FDA", "FDA-2008-N-0326", "Animal Health Institute - Request for Extension Comment Due Date", "Other", "EXT-Request for Extension Comment Due Date", "2008-07-22T04:00:00Z", 2008, 7, "2008-07-22T04:00:00Z", null, "2013-07-27T22:18:59Z", null, 0, 0, "0900006480685084"], ["FDA-2008-N-0326-0023", "FDA", "FDA-2008-N-0326", "American Veterinary Medical Association - Request for Extension Comment Due Date", "Other", "EXT-Request for Extension Comment Due Date", "2008-07-18T04:00:00Z", 2008, 7, "2008-07-18T04:00:00Z", null, "2013-07-27T22:18:53Z", null, 0, 0, "090000648067ffa0"], ["FDA-2008-N-0326-0001", "FDA", "FDA-2008-N-0326", "New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition", "Rule", "NFR-Notice of Final Rule", "2008-07-03T04:00:00Z", 2008, 7, "2008-07-03T04:00:00Z", "2008-09-04T03:59:59Z", "2012-07-05T02:02:01Z", "E8-15052", 0, 0, "0900006480653961"], ["FDA-2008-N-0326-0008", "FDA", "FDA-2008-N-0326", "Reference 7 - CDC, National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS): Human Isolates Final Report, 2004 re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background", "Supporting & Related Material", "Background Material", "2008-07-03T04:00:00Z", 2008, 7, null, null, "2012-07-04T16:56:03Z", null, 0, 0, "090000648064e468"], ["FDA-2008-N-0326-0011", "FDA", "FDA-2008-N-0326", "Reference 10 - Clinical & Laboratory Standards Institute, Performance Standards for Antimicrobial Susceptibility Testing re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background", "Supporting & Related Material", "Background Material", "2008-07-03T04:00:00Z", 2008, 7, null, null, "2012-07-04T16:56:46Z", null, 0, 0, "090000648064e62b"], ["FDA-2008-N-0326-0004", "FDA", "FDA-2008-N-0326", "Reference 3 - B-Lactam Resistance & B-lactamases in Bacteria of Animal Origin re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background", "Supporting & Related Material", "Background Material", "2008-07-03T04:00:00Z", 2008, 7, null, null, "2012-07-04T16:55:08Z", null, 0, 0, "090000648064e439"], ["FDA-2008-N-0326-0005", "FDA", "FDA-2008-N-0326", "Reference 4 - EARSS Annual Report 2005 Pages 1-147 2006 Bilthoven, The Netherlands, European Antimicrobial Resistance Surveillance System re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background", "Supporting & Related Material", "Background Material", "2008-07-03T04:00:00Z", 2008, 7, null, null, "2012-07-04T16:55:22Z", null, 0, 0, "090000648064e441"], ["FDA-2008-N-0326-0010", "FDA", "FDA-2008-N-0326", "Reference 9 - American Society for Microbiology, B-Lactamaces in Laboratory & Clinical Resistance re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background", "Supporting & Related Material", "Background Material", "2008-07-03T04:00:00Z", 2008, 7, null, null, "2012-07-04T16:56:34Z", null, 0, 0, "090000648064e61f"], ["FDA-2008-N-0326-0014", "FDA", "FDA-2008-N-0326", "List of References re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background", "Supporting & Related Material", "Background Material", "2008-07-03T04:00:00Z", 2008, 7, null, null, "2012-07-04T16:57:28Z", null, 0, 0, "0900006480654597"], ["FDA-2008-N-0326-0009", "FDA", "FDA-2008-N-0326", "Reference 8 - American Society for Microbiology, DNA Sequence Analysis of Regions Surrounding blacmy-2 from Multiple Salmonella Plasmid Backbones re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background", "Supporting & Related Material", "Background Material", "2008-07-03T04:00:00Z", 2008, 7, null, null, "2012-07-04T16:56:13Z", null, 0, 0, "090000648064e603"], ["FDA-2008-N-0326-0002", "FDA", "FDA-2008-N-0326", "Reference 1 - Williams et al Antibiotics in Laboratory Medicine re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background", "Supporting & Related Material", "Background Material", "2008-07-03T04:00:00Z", 2008, 7, null, null, "2012-07-04T16:54:43Z", null, 0, 0, "090000648064e32d"], ["FDA-2008-N-0326-0007", "FDA", "FDA-2008-N-0326", "Reference 6 - CDC Enteric Disease Branch, Animal-to-man Transmission of Antimicrobial-resistant Salmonella: Investigations of United States Outbreaks, 1971-1983 re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background", "Supporting & Related Material", "Background Material", "2008-07-03T04:00:00Z", 2008, 7, null, null, "2012-07-04T16:55:50Z", null, 0, 0, "090000648064e45d"], ["FDA-2008-N-0326-0003", "FDA", "FDA-2008-N-0326", "Reference 2 - US Food & Drug Administration, Maxipime (Cefepime Hydrochloride) for Injection, Powder, For Solution (Bristol-Myers Squibb) re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background", "Supporting & Related Material", "Background Material", "2008-07-03T04:00:00Z", 2008, 7, null, null, "2012-07-04T16:54:56Z", null, 0, 0, "090000648064e42a"], ["FDA-2008-N-0326-0006", "FDA", "FDA-2008-N-0326", "Reference 5 - USDA/ARS National Antimicrobial Resistance Montoring System, Veterinary Isolates Data re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background", "Supporting & Related Material", "Background Material", "2008-07-03T04:00:00Z", 2008, 7, null, null, "2012-07-04T16:55:34Z", null, 0, 0, "090000648064e44b"], ["FDA-2008-N-0326-0012", "FDA", "FDA-2008-N-0326", "Reference 11 - J. of Antimicrobial Chemotherapy, CTX-M: Changing the Face of ESBLs In Europe re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background", "Supporting & Related Material", "Background Material", "2008-07-03T04:00:00Z", 2008, 7, null, null, "2012-07-04T16:56:59Z", null, 0, 0, "090000648064e63a"], ["FDA-2008-N-0326-0013", "FDA", "FDA-2008-N-0326", "Reference 13 - Summary of Data from Hatchery Inspections Conducted September-October, 2001 re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background", "Supporting & Related Material", "Background Material", "2008-07-03T04:00:00Z", 2008, 7, null, null, "2012-07-04T16:57:14Z", null, 0, 0, "090000648064e666"]], "truncated": false, "filtered_table_rows_count": 33, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "FDA-2008-N-0326"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0326", "results": [{"value": "FDA", "label": "FDA", "count": 33, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2008-N-0326", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0326", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 20, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0326&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Other", "label": "Other", "count": 9, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0326&document_type=Other", "selected": false}, {"value": "Rule", "label": "Rule", "count": 4, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0326&document_type=Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0326", "results": [{"value": 2008, "label": 2008, "count": 25, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0326&posted_year=2008", "selected": false}, {"value": 2012, "label": 2012, "count": 8, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0326&posted_year=2012", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0326&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0326&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0326&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0326&_facet=comment_start_date"}, {"name": "comment_end_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0326&_facet=comment_end_date"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0326&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0326&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0326&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2008-N-0326&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 65.0745069142431, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}